OTCMKTS:PBIO - Pressure Biosciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.06 0.00 (0.00 %)
(As of 05/26/2019 04:00 PM ET)
Previous Close$3.06
Today's Range$3.06 - $3.06
52-Week Range$1.52 - $4.10
Volume204 shs
Average Volume12,685 shs
Market Capitalization$5.71 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23
Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, PULSE Tubes, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions in the United States, Europe, and Asia. Pressure BioSciences, Inc. has a collaboration with NutraFuels, Inc. for the development of water-soluble Nanoemulsion-based nutraceuticals. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.

Receive PBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for PBIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PBIO
CUSIPN/A
Phone508-230-1828

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.46 million
Book Value($3.63) per share

Profitability

Net Income$-9,700,000.00
Net Margins-402.53%

Miscellaneous

Employees17
Market Cap$5.71 million
Next Earnings Date5/28/2019 (Estimated)
OptionableNot Optionable

Pressure Biosciences (OTCMKTS:PBIO) Frequently Asked Questions

What is Pressure Biosciences' stock symbol?

Pressure Biosciences trades on the OTCMKTS under the ticker symbol "PBIO."

How were Pressure Biosciences' earnings last quarter?

Pressure Biosciences Inc (OTCMKTS:PBIO) posted its quarterly earnings data on Tuesday, May, 15th. The company reported ($1.64) earnings per share (EPS) for the quarter. The company earned $0.61 million during the quarter. View Pressure Biosciences' Earnings History.

When is Pressure Biosciences' next earnings date?

Pressure Biosciences is scheduled to release their next quarterly earnings announcement on Tuesday, May 28th 2019. View Earnings Estimates for Pressure Biosciences.

Has Pressure Biosciences been receiving favorable news coverage?

Media coverage about PBIO stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Pressure Biosciences earned a daily sentiment score of -1.8 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term.

Who are some of Pressure Biosciences' key competitors?

What other stocks do shareholders of Pressure Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure Biosciences investors own include Allena Pharmaceuticals (ALNA), Inpixon (INPX), LightPath Technologies (LPTH), Precipio (PRPO), InterCloud Systems (ICLD), Monaker Group (MKGI), Arca Biopharma (ABIO), Acer Therapeutics (ACER), Amedica (AMDA) and ArQule (ARQL).

Who are Pressure Biosciences' key executives?

Pressure Biosciences' management team includes the folowing people:
  • Mr. Richard T. Schumacher, Founder, Pres, CEO, Treasurer, Clerk, Sec. & Director (Age 69)
  • Dr. Alexander V. Lazarev, Chief Science Officer (Age 54)
  • Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D., Sr. VP of Engineering (Age 64)
  • Mr. Richard P. Thomley, Acting Chief Financial Officer (Age 67)
  • Dr. Bradford Addison Young, Sr. VP & Chief Commercial Officer (Age 50)

How do I buy shares of Pressure Biosciences?

Shares of PBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pressure Biosciences' stock price today?

One share of PBIO stock can currently be purchased for approximately $3.06.

How big of a company is Pressure Biosciences?

Pressure Biosciences has a market capitalization of $5.71 million and generates $2.46 million in revenue each year. Pressure Biosciences employs 17 workers across the globe.

What is Pressure Biosciences' official website?

The official website for Pressure Biosciences is http://www.pressurebiosciences.com/.

How can I contact Pressure Biosciences?

Pressure Biosciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The company can be reached via phone at 508-230-1828 or via email at [email protected]


MarketBeat Community Rating for Pressure Biosciences (OTCMKTS PBIO)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  138
MarketBeat's community ratings are surveys of what our community members think about Pressure Biosciences and other stocks. Vote "Outperform" if you believe PBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/26/2019 by MarketBeat.com Staff

Featured Article: Do You Need a Fiduciary?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel